Reducing infectious malaria parasites in donated blood could help prevent transmission

April 21, 2016, University of Cambridge
Credit: CDC

A technique for reducing the number of infectious malaria parasites in whole blood could significantly reduce the number of cases of transmission of malaria through blood transfusion, according to a collaboration between researchers in Cambridge, UK, and Kumasi, Ghana.

Malaria is a blood-borne disease caused by the parasite - in west Africa, this is mainly Plasmodium falciparum. The parasite is mainly transmitted to humans through . In sub-Saharan Africa, is endemic and a substantial proportion of the population carries the parasite, even when individuals do not show any symptoms. Only a few blood centres screen donor blood of the parasite and hence there is a high risk of through transfusion.

Because of resource limitations, the most common red blood cell product transfused is whole blood. A half of all in Ghana carry detectable levels of malaria parasites in the blood and as many as one in four (between 14-28%) of blood recipients become infected.

The Mirasol pathogen reduction technology system, developed by the US-based Japanese company Terumo BCT, has been developed to treat whole blood using ultraviolet light energy and riboflavin (vitamin B2) to reduce the parasite load and to inactivate white blood cells. It has been shown to reduce P. falciparum load in vitro and to maintain adequate blood quality during 21 days of cold storage.

In a study published today in The Lancet and funded by Terumo BCT, researchers report the results of the African Investigation of the Mirasol System (AIMS) trial, which explored whether the use of blood treated with Mirasol would prevent the transmission of malaria to patients with anaemia being supported with whole blood transfusion.

"In developing countries, blood supplies are often contaminated and blood banking systems cannot afford the newest technologies for detecting blood-borne pathogens," explains Professor Jean-Pierre Allain from the Department of Haematology at the University of Cambridge. "Technologies aimed at reducing the levels of parasites or infectious agents in the blood could benefit individual patients and also health-care systems."

The trial involved 214 patients, 107 of whom received Mirasol-treated blood, the remainder of whom received the normal blood products. Overall, 65 patients who previously were free of detectable parasites were transfused with blood retrospectively found to contain parasites - 28 of these blood products had been treated with Mirasol, 37 were untreated.

The incidence of transfusion-transmitted malaria was significantly lower for those patients who received the treated blood (one out of 28 patients, or 4%) compared to the untreated group (eight out of 37 patients, or 22%).

At the same time, the safety profile did not differ for patients receiving treated or untreated whole blood units. The treated whole blood group had fewer allergic reactions to the transfusion (5% vs 8%) and fewer overall reactions (8% vs 13%), possibly because of the technology also inactivates white blood cells including immune cells.

The researchers recognise that the overall number of transmissions was small, reducing the power of the study, but believe it still provides a clear indication that the Mirasol system could make a dramatic difference to the number of cases of malaria transmission via .

"This could be a real game-changer for blood safety in sub-Saharan African," adds Dr Shirley Owusu-Ofori from the Transfusion Medicine Unit, Komfo Anokye Teaching Hospital, Kumasi, Ghana. "Reduced transfusion-transmissions of infectious agents means a more stable supply, reduced costs for the treatment of preventable infections, and direct benefits to women and children who are especially vulnerable to malaria."

Explore further: Cracking the code of the malaria parasite may help stop transmission

More information: Allain, JP et al. Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet; 23 April 2016.

Related Stories

Cracking the code of the malaria parasite may help stop transmission

April 15, 2016
The most dangerous malaria parasite, Plasmodium falciparum, is responsible for nearly half a million deaths annually across Africa and Southeast Asia. Of increasing concern, this parasite is now developing resistance to common ...

Shorter times to blood transfusion associated with decreased death risk in trauma patients

April 14, 2016
Patients who get blood quickly after severe injuries are less likely to die, according to researchers from the University of Cincinnati (UC) Department of Emergency Medicine.

Potential pathway for emergence of zoonotic malaria identified

April 4, 2016
The parasite responsible for a form of malaria now spreading from macaques to humans in South Asia could evolve to infect humans more efficiently, a step towards enhanced transmission between humans, according to a new study ...

Malaria parasite's essential doorway into red blood cells illuminated

May 7, 2015
Researchers at Harvard T. H. Chan School of Public Health and the Broad Institute have identified a protein on the surface of human red blood cells that serves as an essential entry point for invasion by the malaria parasite. ...

Recommended for you

Deadly Rift Valley fever: New insight, and hope for the future

July 19, 2018
Health control measures alone could be ineffective in the long term fight against the deadly Rift Valley fever which affects both humans and animals, a new study in the journal PNAS reports.

New guidelines to diagnose, manage rare endocrine disorders

July 19, 2018
International guidelines have been published for the first time to help doctors around the globe diagnose and manage patients with a very rare set of endocrine diseases known as pseudohypoparathyroidism and its related disorders, ...

Overuse of antibiotics not what the doctor ordered

July 19, 2018
With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community ...

Alcohol-related cirrhosis deaths skyrocket in young adults

July 18, 2018
Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

Hidden blood in feces may signal deadly conditions

July 17, 2018
(HealthDay)—Even if it's not visible to the naked eye, blood in the stool can be serious—a sign of a potentially fatal disease other than colon cancer, new research suggests.

Childhood abuse linked to greater risk of endometriosis, study finds

July 17, 2018
Endometriosis, a painful condition that affects one in 10 reproductive-age women in the U.S., has been linked to childhood physical and sexual abuse, according to findings published today in the journal Human Reproduction.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.